INTEGRATED BIOPHARMA INC (INBP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 25M 50M 75M Q4 '14: 33.7M Q1 '15: 33.1M Q2 '15: 34.6M Q3 '15: 36.7M Q4 '15: 37.5M Q1 '16: 38.4M Q2 '16: 38.5M Q3 '16: 39.8M Q4 '16: 42.2M Q1 '17: 45.4M Q2 '17: 47.4M Q3 '17: 47.1M Q4 '17: 47M Q1 '18: 44M Q2 '18: 42.5M Q3 '18: 42.4M Q4 '18: 43.7M Q1 '19: 44.2M Q2 '19: 45.4M Q3 '19: 49M Q4 '19: 50M Q1 '20: 51.1M Q2 '20: 53.3M Q3 '20: 52.8M Q4 '20: 52.8M Q1 '21: 56.5M Q2 '21: 56.6M Q3 '21: 60M Q4 '21: 63.6M Q1 '22: 61.1M Q2 '22: 61.5M Q3 '22: 60M Q4 '22: 56.2M Q1 '23: 55.8M Q2 '23: 53.5M Q3 '23: 50.9M Q4 '23: 50.7M Q1 '24: 51.3M Q2 '24: 50.5M Q3 '24: 50.6M Q4 '24: 50.3M Q1 '25: 51M Q2 '25: 52.1M Q3 '25: 52.9M Q4 '25: 54.4M Q1 '26: 53.4M Q2 '26: 52.1M Q3 '26: 48.3M Q1 '16 Q3 '17 Q1 '19 Q3 '20 Q1 '22 Q3 '23 Q1 '25 Q3 '26

Gross Profit TTM

0 3.5M 7M 10.5M Q4 '11: 6.2M Q1 '12: 8M Q2 '12: 9.7M Q3 '12: 9M Q4 '12: 7.6M Q1 '13: 6.4M Q2 '13: 5.1M Q3 '13: 5M Q4 '13: 5.5M Q1 '14: 5.5M Q2 '14: 5.9M Q3 '14: 5.4M Q4 '14: 4.9M Q1 '15: 4.6M Q2 '15: 4.4M Q3 '15: 4.5M Q4 '15: 4.4M Q1 '16: 4.4M Q2 '16: 4.1M Q3 '16: 4.6M Q4 '16: 5.5M Q1 '17: 6.3M Q2 '17: 6.8M Q3 '17: 6.9M Q4 '17: 6.7M Q1 '18: 5.5M Q2 '18: 5.1M Q3 '18: 5.2M Q4 '18: 5M Q1 '19: 5.2M Q2 '19: 5.5M Q3 '19: 6.1M Q4 '19: 6.2M Q1 '20: 6.4M Q2 '20: 7.1M Q3 '20: 6.9M Q4 '20: 6.7M Q1 '21: 7.7M Q2 '21: 7.8M Q3 '21: 8.7M Q4 '21: 9.5M Q1 '22: 8.5M Q2 '22: 8.1M Q3 '22: 7.4M Q4 '22: 6.6M Q1 '23: 6.1M Q2 '23: 5.4M Q3 '23: 4.5M Q4 '23: 4.1M Q1 '24: 3.9M Q2 '24: 3.3M Q3 '24: 3.6M Q4 '24: 3.9M Q1 '25: 4.4M Q2 '25: 5.1M Q3 '25: 5.4M Q4 '25: 5.6M Q1 '26: 5.2M Q2 '26: 4.1M Q3 '26: 2.2M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Operating Income TTM

-2M 0 2M 4M 6M Q4 '11: -362K Q1 '12: 200K Q2 '12: 839K Q3 '12: 768K Q4 '12: -506K Q1 '13: -747K Q2 '13: -1.2M Q3 '13: -642K Q4 '13: 1.1M Q1 '14: 1.4M Q2 '14: 2M Q3 '14: 1.6M Q4 '14: 1.4M Q1 '15: 1.1M Q2 '15: 921K Q3 '15: 1.1M Q4 '15: 932K Q1 '16: 968K Q2 '16: 737K Q3 '16: 1.2M Q4 '16: 2.1M Q1 '17: 3M Q2 '17: 3.4M Q3 '17: 3.4M Q4 '17: 3.2M Q1 '18: 2M Q2 '18: 1.7M Q3 '18: 1.9M Q4 '18: 1.7M Q1 '19: 1.9M Q2 '19: 2.2M Q3 '19: 2.8M Q4 '19: 2.7M Q1 '20: 2.8M Q2 '20: 3.5M Q3 '20: 3.2M Q4 '20: 3.3M Q1 '21: 4.3M Q2 '21: 4.3M Q3 '21: 5.1M Q4 '21: 5.8M Q1 '22: 4.9M Q2 '22: 4.3M Q3 '22: 3.6M Q4 '22: 2.7M Q1 '23: 2.2M Q2 '23: 1.4M Q3 '23: 479K Q4 '23: 120K Q1 '24: 36K Q2 '24: -383K Q3 '24: -72K Q4 '24: 251K Q1 '25: 795K Q2 '25: 1.4M Q3 '25: 1.8M Q4 '25: 2M Q1 '26: 1.7M Q2 '26: 577K Q3 '26: -1.2M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Net Income TTM

-6M -3M 0 3M 6M 9M Q4 '11: -2.3M Q1 '12: -1.9M Q2 '12: -2.3M Q3 '12: -2.1M Q4 '12: -2.7M Q1 '13: -4M Q2 '13: -2.4M Q3 '13: -2.2M Q4 '13: 93K Q1 '14: 1.4M Q2 '14: 943K Q3 '14: 1M Q4 '14: 131K Q1 '15: 236K Q2 '15: 386K Q3 '15: 730K Q4 '15: 735K Q1 '16: 573K Q2 '16: -37K Q3 '16: 102K Q4 '16: 958K Q1 '17: 1.4M Q2 '17: 1.4M Q3 '17: 1.6M Q4 '17: 2.3M Q1 '18: 1.5M Q2 '18: 1.2M Q3 '18: 1.4M Q4 '18: 679K Q1 '19: 1M Q2 '19: 1.6M Q3 '19: 2.1M Q4 '19: 1.7M Q1 '20: 1.8M Q2 '20: 2.6M Q3 '20: 2.6M Q4 '20: 4.1M Q1 '21: 4.8M Q2 '21: 5.1M Q3 '21: 5.4M Q4 '21: 8M Q1 '22: 7.5M Q2 '22: 7.3M Q3 '22: 6.9M Q4 '22: 3.8M Q1 '23: 3.3M Q2 '23: 2.2M Q3 '23: 1.4M Q4 '23: -34K Q1 '24: -58K Q2 '24: -385K Q3 '24: -116K Q4 '24: 112K Q1 '25: 430K Q2 '25: 928K Q3 '25: 1.3M Q2 '13 Q1 '15 Q4 '16 Q3 '18 Q2 '20 Q1 '22 Q4 '23 Q3 '25

Cost of Revenue TTM

0 20M 40M 60M Q4 '18: 38.7M Q1 '19: 39M Q2 '19: 40M Q3 '19: 42.9M Q4 '19: 43.8M Q1 '20: 44.7M Q2 '20: 46.2M Q3 '20: 46M Q4 '20: 46M Q1 '21: 48.8M Q2 '21: 48.7M Q3 '21: 51.4M Q4 '21: 54.1M Q1 '22: 52.6M Q2 '22: 53.4M Q3 '22: 52.6M Q4 '22: 49.7M Q1 '23: 49.7M Q2 '23: 48M Q3 '23: 46.5M Q4 '23: 46.6M Q1 '24: 47.4M Q2 '24: 47.2M Q3 '24: 47M Q4 '24: 46.4M Q1 '25: 46.6M Q2 '25: 47M Q3 '25: 47.5M Q4 '25: 48.8M Q1 '26: 48.2M Q2 '26: 48M Q3 '26: 46M Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Operating Cash Flow TTM

-2M 0 2M 4M 6M Q4 '11: 392K Q1 '12: 123K Q2 '12: -1M Q3 '12: 33K Q4 '12: -771K Q1 '13: -1.1M Q2 '13: -1.5M Q3 '13: -1.6M Q4 '13: -1.4M Q1 '14: -543K Q2 '14: 541K Q3 '14: 1.5M Q4 '15: -113K Q1 '16: 818K Q2 '16: 201K Q3 '16: -974K Q4 '16: -594K Q1 '17: -1.6M Q2 '17: 1.1M Q3 '17: 1.4M Q4 '17: 397K Q1 '18: 2.5M Q2 '18: 490K Q3 '18: 525K Q4 '18: 1.2M Q1 '19: 157K Q2 '19: -386K Q3 '19: -474K Q4 '19: 328K Q1 '20: 1.4M Q2 '20: 2.3M Q3 '20: 4.2M Q4 '20: 1.3M Q1 '21: 1.6M Q2 '21: 1.4M Q3 '21: 128K Q4 '21: 3M Q1 '22: 3.2M Q2 '22: 2.6M Q3 '22: 2.1M Q4 '22: 4.1M Q1 '23: 3M Q2 '23: 4.3M Q3 '23: 5.1M Q4 '23: 1.2M Q1 '24: 1.6M Q2 '24: -230K Q3 '24: -57K Q4 '24: 943K Q1 '25: 287K Q2 '25: 2.3M Q3 '25: 1.3M Q4 '25: 2.1M Q1 '26: 2.7M Q2 '26: 3.1M Q3 '26: 3M Q2 '13 Q1 '16 Q4 '17 Q3 '19 Q2 '21 Q1 '23 Q4 '24 Q3 '26

Free Cash Flow TTM

-2M 0 2M 4M 6M Q4 '11: 91K Q1 '12: -34K Q2 '12: -1.1M Q3 '12: -105K Q4 '12: -926K Q1 '13: -1.3M Q2 '13: -1.6M Q3 '13: -1.7M Q4 '13: -1.5M Q1 '14: -567K Q2 '14: 490K Q3 '14: 1.4M Q4 '15: -348K Q1 '16: 710K Q2 '16: 114K Q3 '16: -1M Q4 '16: -703K Q1 '17: -1.7M Q2 '17: 957K Q3 '17: 1.1M Q4 '17: 70K Q1 '18: 2.1M Q2 '18: 36K Q3 '18: 292K Q4 '18: 921K Q1 '19: -1K Q2 '19: -710K Q3 '19: -855K Q4 '19: -86K Q1 '20: 966K Q2 '20: 2.1M Q3 '20: 4M Q4 '20: 1.1M Q1 '21: 1.4M Q2 '21: 1.2M Q3 '21: -78K Q4 '21: 2.8M Q1 '22: 2.9M Q2 '22: 2.1M Q3 '22: 1.5M Q4 '22: 3.6M Q1 '23: 2.6M Q2 '23: 4.1M Q3 '23: 5M Q4 '23: 1.1M Q1 '24: 1.4M Q2 '24: -326K Q3 '24: -482K Q4 '24: 390K Q1 '25: -284K Q2 '25: 1.7M Q3 '25: 941K Q4 '25: 1.9M Q1 '26: 2.4M Q2 '26: 2.8M Q3 '26: 2.8M Q2 '13 Q1 '16 Q4 '17 Q3 '19 Q2 '21 Q1 '23 Q4 '24 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '11: 20.6M Q2 '11: 20.8M Q3 '11: 20.8M Q1 '12: 20.9M Q2 '12: 21M Q3 '12: 21M Q1 '13: 21.1M Q2 '13: 29.5M Q3 '13: 21.1M Q1 '14: 29.4M Q2 '14: 29.4M Q3 '14: 21.1M Q1 '15: 29.5M Q2 '15: 29.3M Q3 '15: 21.1M Q1 '16: 21.2M Q2 '16: 21.1M Q3 '16: 21.3M Q1 '17: 21.2M Q2 '17: 21.1M Q3 '17: 30.8M Q1 '18: 21.1M Q2 '18: 21.1M Q3 '18: 30.2M Q1 '19: 28M Q2 '19: 29.9M Q3 '19: 30.1M Q1 '20: 30.7M Q2 '20: 30.6M Q3 '20: 30.9M Q1 '21: 31.8M Q2 '21: 32.1M Q3 '21: 32.9M Q1 '22: 32.6M Q2 '22: 32.4M Q3 '22: 32.4M Q1 '23: 29.9M Q2 '23: 29.9M Q3 '23: 31.5M Q1 '24: 30M Q2 '24: 30.1M Q3 '24: 30.7M Q1 '25: 30.6M Q2 '25: 31.3M Q3 '25: 31.5M Q1 '26: 31.4M Q2 '26: 31.1M Q3 '26: 31.1M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.27 -0.18 -0.09 0.00 0.09 0.18 0.27 Q4 '11: -0.11 Q1 '12: -0.09 Q2 '12: -0.11 Q3 '12: -0.11 Q4 '12: -0.13 Q1 '13: -0.20 Q2 '13: -0.13 Q3 '13: -0.12 Q4 '13: 0.00 Q1 '14: 0.06 Q2 '14: 0.04 Q3 '14: 0.05 Q4 '14: 0.01 Q1 '15: 0.01 Q2 '15: 0.01 Q3 '15: 0.02 Q4 '15: 0.01 Q1 '16: 0.01 Q2 '16: 0.00 Q3 '16: 0.01 Q4 '16: 0.05 Q1 '17: 0.07 Q2 '17: 0.07 Q3 '17: 0.08 Q4 '17: 0.10 Q1 '18: 0.06 Q2 '18: 0.04 Q3 '18: 0.04 Q4 '18: 0.01 Q1 '19: 0.03 Q2 '19: 0.06 Q3 '19: 0.08 Q4 '19: 0.06 Q1 '20: 0.06 Q2 '20: 0.08 Q3 '20: 0.08 Q4 '20: 0.13 Q1 '21: 0.15 Q2 '21: 0.16 Q3 '21: 0.17 Q4 '21: 0.25 Q1 '22: 0.24 Q2 '22: 0.23 Q3 '22: 0.22 Q4 '22: 0.13 Q1 '23: 0.11 Q2 '24: -0.01 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.01 Q2 '25: 0.03 Q3 '25: 0.04 Q4 '25: 0.04 Q1 '26: 0.03 Q2 '26: -0.01 Q3 '26: -0.06 Q2 '13 Q1 '15 Q4 '16 Q3 '18 Q2 '20 Q1 '22 Q4 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.